Amgen
-
Amgen, UCB team up with NASA to conduct preclinical trial on final shuttle mission
Amgen and UCB announced that they are collaborating with the NASA Ames Research Center to conduct a preclinical test of a sclerostin antibody. The experiment will take place aboard space shuttle Atlantis, on the final NASA shuttle mission, Space Shut…
Amgen | 06 July 2011
-
Amgen receives executive summary on independent review of ESAs in oncology
Amgen says it has received a summary of preliminary results from the Cochrane Collaboration's independent meta-analysis of patient-level data from previously conducted, randomized, controlled, clinical studies evaluating erythropoiesis-stimulating ag…
Amgen | 08 October 2008
-
Amgen licenses molecule to Ortho-McNeil-Janssen Pharmaceuticals
Amgen says it has licensed a clinical stage molecule for the treatment of chronic and neuropathic pain to Ortho-McNeil-Janssen Pharmaceuticals, Inc. (OMJPI), a Johnson & Johnson company. The terms of the agreement include a $50 million upfront pa…
Amgen | 08 August 2008
-
Kyowa Hakko and Amgen Enter Licensing Agreement for Anti-Ccr4 Humanized Monoclonal Antibody
Kyowa Hakko Kogyo and Amgen have announced an agreement under which Amgen will receive an exclusive license to develop and commercialize Kyowa Hakko's humanized monoclonal antibody KW-0761 worldwide, except in Japan, Korea, China and Taiwan. Kyowa Ha…
Amgen | 01 March 2008
-
Amgen And Takeda Announce Exclusive Collaboration In Japan On Up To 13 Amgen Clinical Candidates
Amgen and Takeda Pharmaceutical Company Limited have announced an agreement under which Takeda will develop and commercialize for the Japanese market up to 13 molecules from Amgen’s pipeline, one of which is included as an option. This collabor…
Amgen | 08 February 2008
